You are a biotechnology or cell therapy company, located in the US, Canada, South Korea or Japan, searching for European suppliers or partners to help you determine and choose optimal clinical supply or commercial biomanufacturing facilities in the European Union.
An optimal cGMP facility may be owned and operated by a Contract Manufacturer Organization (CMO), a Contract Research Organization (CRO) or could be an available space that you might acquire or lease.
Biotech Consult can layout the manufacturing landscape and possible options for the expansion of your business into the European Union, taking into account the biologistics issues and solutions providers (major airports, road, train).
Based on a first exhaustive list and features determined with you, Biotech Consult can select a short list and recommend the best suited manufacturing sites and infrastructures.
You can afterwards qualify those infrastructures by yourself or execute that work through our services.
Biotech Consult can further qualify the European biotech manufacturing actors with its dedicated partners :
European overview of the available cell therapy or biologics manufacturing facilities, e.g . CMOs, institutional infrastructures (university hospitals, blood banks,…) or even private companies with overcapacities, whatever their size and specific biologics manufacturing expertise may be.
Deliverable : File featuring ~25 dedicated sites, classified by location (country/city), GMP area surface (and class B-C-D range if available), non GMP area surface, licensed manufacturer accreditation date and focus-expertise (and references if available).